These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12042029

  • 1. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension.
    Kato S, Sugimura H, Kishiro I, Machida M, Suzuki H, Kaneko N.
    Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029
    [Abstract] [Full Text] [Related]

  • 2. Changes of sequestered leukocytes and platelets by inhalation prostaglandin E(1) in the pulmonary microvasculature of rats with monocrotaline-induced pulmonary hypertension.
    Kato S, Kishiro I, Sugimura H, Machida S, Fuse D, Kaneko N.
    J Vasc Res; 2002 Jun; 39(1):83-7. PubMed ID: 11844940
    [Abstract] [Full Text] [Related]

  • 3. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S, Tanita T, Hoshikawa Y, Song C, Maeda S, Tabata T, Noda M, Ueda S, Ashino Y, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [Abstract] [Full Text] [Related]

  • 4. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 5. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
    Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
    [Abstract] [Full Text] [Related]

  • 6. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.
    Cardiovasc Ther; 2010 Feb; 28(1):23-9. PubMed ID: 20074256
    [Abstract] [Full Text] [Related]

  • 7. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.
    J Androl; 2009 Dec; 30(5):495-504. PubMed ID: 19201699
    [Abstract] [Full Text] [Related]

  • 12. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP.
    Circulation; 2006 Aug 29; 114(9):912-20. PubMed ID: 16940204
    [Abstract] [Full Text] [Related]

  • 13. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M.
    Crit Care Med; 2008 Mar 29; 36(3):873-80. PubMed ID: 18431275
    [Abstract] [Full Text] [Related]

  • 14. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.
    Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263
    [Abstract] [Full Text] [Related]

  • 15. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 30; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 16. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L, Zhou TF, Liu HM, Li M, Dou H, Tang ZH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 30; 38(3):463-5, 479. PubMed ID: 17593832
    [Abstract] [Full Text] [Related]

  • 17. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
    Sun CK, Lee FY, Sheu JJ, Yuen CM, Chua S, Chung SY, Chai HT, Chen YT, Kao YH, Chang LT, Yip HK.
    J Pharmacol Exp Ther; 2009 Sep 30; 330(3):718-26. PubMed ID: 19528354
    [Abstract] [Full Text] [Related]

  • 18. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
    Kodama K, Adachi H.
    J Pharmacol Exp Ther; 1999 Aug 30; 290(2):748-52. PubMed ID: 10411587
    [Abstract] [Full Text] [Related]

  • 19. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 20. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R, Altura BT, Altura BM.
    Magnesium; 1989 Jul 01; 8(2):110-6. PubMed ID: 2526910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.